A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Figure 5.Nomogram of the DEGTGs in LUAD. Abbreviations: DEGTGs: differentially expressed Gefitinib target genes; LUAD: lung adenocarcinoma.